Results for the year - Share- based payment (Details)
|
|
|
1 Months Ended |
12 Months Ended |
14 Months Ended |
|
|
|
|
Aug. 02, 2017
EUR (€)
|
Aug. 02, 2017
USD ($)
|
May 06, 2016 |
Nov. 30, 2017
DKK (kr)
kr / shares
|
Nov. 30, 2017
EUR (€)
EquityInstruments
|
Nov. 30, 2017
USD ($)
EquityInstruments
$ / shares
|
Jun. 30, 2017
USD ($)
EquityInstruments
$ / shares
shares
|
Mar. 31, 2017
USD ($)
EquityInstruments
$ / shares
|
Oct. 31, 2016
USD ($)
EquityInstruments
|
Jun. 30, 2016
USD ($)
EquityInstruments
shares
|
May 31, 2016
USD ($)
EquityInstruments
|
Jan. 31, 2016
EquityInstruments
|
Nov. 30, 2015
EquityInstruments
|
Dec. 31, 2017
DKK (kr)
EquityInstruments
individual
shares
|
Dec. 31, 2017
EUR (€)
EquityInstruments
individual
shares
|
Dec. 31, 2017
USD ($)
EquityInstruments
individual
shares
|
Dec. 31, 2016
USD ($)
EquityInstruments
|
Dec. 31, 2015
USD ($)
item
EquityInstruments
$ / shares
shares
|
Dec. 31, 2014
EquityInstruments
|
Jun. 30, 2017
USD ($)
EquityInstruments
individual
$ / shares
|
Dec. 31, 2017
USD ($)
EquityInstruments
$ / shares
shares
|
Nov. 30, 2017
USD ($)
|
Apr. 30, 2015
EquityInstruments
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares per each ADS prior to the share split | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
1
|
1
|
|
|
|
|
|
|
|
| Number of ordinary shares at the time of share split per each ADS | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10
|
|
|
|
|
|
10
|
|
|
| Number of ordinary shares per each ADS after Capital Reduction | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
2
|
2
|
|
|
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
664,000
|
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,600,000
|
|
|
|
|
|
|
| Expiration period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 years
|
|
|
|
|
|
|
| Aggregate fair value of options granted | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8,200,000
|
|
|
|
|
|
|
| Annulment of ordinary shares outstanding post share split (as a percent) |
80.00%
|
80.00%
|
|
|
80.00%
|
80.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash payment to award holders as a result of annulment of shares |
|
|
|
|
€ 36,200,000
|
$ 43,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reduction in number of outstanding awards as a result of annulment of shares |
|
|
|
|
28,800,000
|
28,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expense recognized when Award is negatively affected by Amendment | $ |
|
|
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholder distribution (Capital Reduction) |
€ 917,700,000
|
$ 1,100,000,000
|
|
|
|
32,200,000
|
|
|
|
|
|
|
|
|
|
$ 1,093,927,000
|
|
|
|
|
|
|
|
| Exercise price | kr |
|
|
|
kr 0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants granted (after share split) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,200,000
|
|
|
|
|
|
| Warrants yield proceeds to the company | $ |
|
|
|
|
|
|
|
$ 49,000
|
|
|
$ 112,000
|
|
|
|
|
|
|
$ 153,000
|
|
|
|
|
|
| Fair value of an ordinary share of the Company on the date of exercise | $ |
|
|
|
|
|
|
|
27.95
|
|
|
18.60
|
|
|
|
|
|
|
33.79
|
|
|
|
|
|
| Fair value of ordinary shares of the company on the date of exercise (after share split) | $ |
|
|
|
|
|
|
|
$ 2.80
|
|
|
$ 1.86
|
|
|
|
|
|
|
$ 3.38
|
|
|
|
|
|
| Warrants exercised |
|
|
|
|
|
|
|
40,000
|
|
|
130,000
|
|
|
|
|
|
|
216,000
|
|
|
|
|
|
| Warrants exercised (after share split) |
|
|
|
|
|
|
|
401,000
|
|
|
1,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consulting agreement term |
|
|
4 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options with exercise price of $28.26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
| Expense recognized during the period | $ |
|
|
|
|
|
$ 11,700,000
|
|
|
|
|
|
|
|
|
|
$ 7,082,000
|
$ 14,288,000
|
$ 13,541,000
|
|
|
|
|
|
| Number of extension awards for which expiration dates extended |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
167,000
|
|
|
|
|
|
| Number of extension awards for which expiration dates extended (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,700,000
|
|
|
|
|
|
| Consultants serving on board of directors | individual |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
| Deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate fair value of options granted | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,400,000
|
|
|
|
|
|
| Granting of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
55,000
|
|
|
|
|
|
| Number of deferred shares granted (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
550,000
|
|
|
|
|
|
| Number of equity awards forfeited |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,842,000
|
2,842,000
|
2,842,000
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
kr 0.01
|
|
$ 0.0016
|
|
|
|
|
|
|
|
| Holders of deferred shares need to remit upon issuance | (per share) |
|
|
|
kr 0.01
|
|
$ 0.0016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 2017 Deferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of shares reduced in subscription of deferred shares |
|
|
|
|
|
|
80.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of deferred shares reduced (after share split) | shares |
|
|
|
|
|
|
720,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expiration period |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate fair value of options granted | $ |
|
|
|
|
|
|
$ 1,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Granting of deferred shares |
|
|
|
|
|
|
90,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of deferred shares granted (after share split) |
|
|
|
|
|
|
900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of deferred shares vest in the event of favourable conclusion of the Interference Proceedings |
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
| Number of deferred shares vest in the event of Interference Proceedings (after share split) |
|
|
|
|
|
|
500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
|
|
|
| Due to the deferred share holders of the company as a result of Capital Reduction |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 1,700,000
|
|
|
|
|
|
$ 2,100,000
|
|
|
| June 2017 Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
825,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
8,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of outstanding share options | $ |
|
|
|
|
|
|
$ 20.35
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 20.35
|
|
|
|
| Exercise price of outstanding share options (after share split) | $ / shares |
|
|
|
|
|
|
$ 2.04
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.04
|
|
|
|
| Vesting term |
|
|
|
|
|
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of shares reduced in subscription of share options |
|
|
|
|
|
|
80.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of share options reduced (after share split) | shares |
|
|
|
|
|
|
6,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expiration period |
|
|
|
|
|
|
6 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate fair value of options granted | $ |
|
|
|
|
|
|
$ 8,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Due to option holders as a result of Capital Reduction |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,900,000
|
|
|
|
|
|
$ 2,200,000
|
|
|
| Amount paid to option holders as a result of the Capital Reduction |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 361,000
|
430,000
|
|
|
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expiring Awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expiring Awards |
|
|
|
|
|
|
|
|
|
|
|
(89,000)
|
1,316,000
|
|
|
|
|
1,405,000
|
|
|
|
|
|
| Expiring awards (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
13,200,000
|
|
|
|
891,000
|
14,100,000
|
|
|
|
|
|
| Expiring awards to be exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
334,000
|
| Expiring awards to be exercised (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,300,000
|
| Replacement Awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Granting of share options or warrants to replace expiring awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,365,000
|
|
|
|
|
|
| Granting of share options or warrants to replace expiring awards (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,600,000
|
|
|
|
|
|
| Replacement awards which can be exercised prior to specified date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
85,000
|
|
|
|
|
|
| Replacement awards which can be exercised prior to specified date (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
847,000
|
|
|
|
|
|
| Additional Awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
362,000
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,600,000
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
| Replacement and Additional Awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate fair value of options granted | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,800,000
|
|
|
|
|
|
| Certain employees, board members and consultants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares available for grant under the Equity Plan | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,100,000
|
|
|
|
|
|
10,100,000
|
|
|
| Shares available for future grant under the Equity Plan | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,100,000
|
|
|
|
|
|
3,100,000
|
|
|
| Number of options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
706,000
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,000,000
|
|
|
|
|
|
| Expiration period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 years
|
|
|
|
|
|
| Certain employees, board members and consultants | Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares available for future grant under the Equity Plan | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,100,000
|
|
|
|
|
|
2,100,000
|
|
|
| Certain employees, board members and consultants | Deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares available for future grant under the Equity Plan | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,000,000
|
|
|
|
|
|
17,000,000
|
|
|
| Board of Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
178,000
|
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,800,000
|
|
|
|
|
|
|
| Board of Directors | June 2017 Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
75,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
750,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employees | Deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Granting of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
|
|
|
|
| Number of deferred shares granted (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
| Consultants | Deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 years
|
|
|
|
|
|
| Granting of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
| Number of deferred shares granted (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 years
|
|
|
|
|
|
| Number of consultants | item |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
| Consultants | June 2016 Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants granted |
|
|
|
|
|
|
|
|
|
89,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants granted (after share split) | shares |
|
|
|
|
|
|
|
|
|
891,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants | $ |
|
|
|
|
|
|
|
|
|
$ 0.56
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants (after share split) | $ |
|
|
|
|
|
|
|
|
|
$ 0.06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non employee consultants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
| Aggregate fair value of options granted | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,200,000
|
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
| Expense recognized during the period | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
615,000
|
$ 892,000
|
$ 2,000,000
|
|
|
|
|
|
| Non employee consultants | Consultant Options, Exercise Price One |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,500,000
|
|
|
|
|
|
| Exercise price of outstanding share options | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 28.26
|
|
|
|
|
|
| Exercise price of outstanding share options (after share split) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.83
|
|
|
$ 2.83
|
|
|
| Number of consultant options vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
2,000,000
|
|
|
| Vesting of option with a exercise price of $2.83 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
|
|
1,000,000
|
|
|
| Weighted average fair value per consultant option applied for recognition of an expense (after share split) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.63
|
0.60
|
$ 1.19
|
|
|
|
|
|
| Number of consultant options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
| Non employee consultants | Consultant Options, Exercise Price Two |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,500,000
|
|
|
|
|
|
| Exercise price of outstanding share options | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 141.30
|
|
|
|
|
|
| Exercise price of outstanding share options (after share split) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 14.13
|
|
|
|
|
|
| Chief Executive Officer | June 2017 Deferred Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Granting of deferred shares |
|
|
|
|
|
|
45,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of deferred shares granted (after share split) |
|
|
|
|
|
|
450,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of deferred shares vest in the event of favourable conclusion of the Interference Proceedings |
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
| Number of deferred shares vest in the event of Interference Proceedings (after share split) |
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
| Chief Executive Officer | Share Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
|
60,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
|
600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of outstanding share options | $ |
|
|
|
|
|
|
|
$ 27.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of outstanding share options (after share split) | $ / shares |
|
|
|
|
|
|
|
$ 2.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
|
|
48 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expiration period |
|
|
|
|
|
|
|
6 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate fair value of options granted | $ |
|
|
|
|
|
|
|
$ 913,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
|
48 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chief Executive Officer | June 2017 Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted |
|
|
|
|
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options granted (after share split) |
|
|
|
|
|
|
3,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Former Employees |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of board members who terminated their roles | individual |
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
2
|
2
|
|
|
|
|
|
|
|
| Number of options or warrants forfeited |
|
|
|
|
|
|
|
|
|
|
|
|
|
564,000
|
564,000
|
564,000
|
|
|
|
|
|
|
|
| Number of options or warrants forfeited (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
5,600,000
|
5,600,000
|
5,600,000
|
|
|
|
|
|
|
|
| Number of options or warrants allowing to hold after modification |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,100,000
|
1,100,000
|
1,100,000
|
|
|
|
|
|
|
|
| Number of options or warrants allowing to hold after modification (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
11,100,000
|
11,100,000
|
11,100,000
|
|
|
|
|
|
|
|
| Expense recognized during the period | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,700,000
|
|
|
|
|
|
|
|
| Amount of reversal of share-based compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,600,000
|
|
|
|
|
|
|
| Former Employees | Deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of equity awards forfeited |
|
|
|
|
|
|
|
|
|
|
|
|
|
284,000
|
284,000
|
284,000
|
|
|
|
|
|
|
|
| Number of equity awards forfeited (after share split) |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,800,000
|
2,800,000
|
2,800,000
|
|
|
|
|
|
|
|
| Chief Financial Officer | Deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 years
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 years
|
|
|
|
|
| Director |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consulting agreement term |
|
|
|
|
|
|
|
|
4 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Director | Deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
|
|
|
4 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate fair value of options granted | $ |
|
|
|
|
|
|
|
|
$ 275,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Granting of deferred shares |
|
|
|
|
|
|
|
|
12,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of deferred shares granted (after share split) |
|
|
|
|
|
|
|
|
125,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
|
|
4 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of outstanding share options | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 12.75
|
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
3 years
|
3 years
|
3 years
|
|
|
|
|
|
|
| Expiration period |
|
|
|
|
|
|
|
|
|
|
|
|
|
6 years
|
6 years
|
6 years
|
|
|
|
|
|
|
|
| Exercise price | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.06
|
$ 0.06
|
|
|
$ 0.0016
|
$ 0.0016
|
|
| Option exercise price (after share split) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.28
|
|
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
3 years
|
3 years
|
3 years
|
|
|
|
|
|
|
| Minimum | Certain employees, board members and consultants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
| Minimum | Non employee consultants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of outstanding share options (after share split) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.09
|
|
|
|
|
|
| Exercise price | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 20.90
|
|
|
|
|
|
| Option exercise price (after share split) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.09
|
|
|
|
|
|
| Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of outstanding share options | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 21.95
|
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
5 years
|
5 years
|
4 years
|
|
|
|
|
|
|
| Expiration period |
|
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
10 years
|
10 years
|
|
|
|
|
|
|
|
| Exercise price | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.20
|
$ 3.69
|
|
|
$ 6.92
|
$ 14.13
|
|
| Option exercise price (after share split) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.20
|
|
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
5 years
|
5 years
|
4 years
|
|
|
|
|
|
|
| Maximum | Certain employees, board members and consultants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 years
|
|
|
|
|
|
| Vesting term of deferred shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 years
|
|
|
|
|
|
| Maximum | Non employee consultants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 36.85
|
|
|
|
|
|
| Option exercise price (after share split) | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.69
|
|
|
|
|
|